629 related articles for article (PubMed ID: 17397237)
41. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
[TBL] [Abstract][Full Text] [Related]
42. Three new consensus QSAR models for the prediction of Ames genotoxicity.
Votano JR; Parham M; Hall LH; Kier LB; Oloff S; Tropsha A; Xie Q; Tong W
Mutagenesis; 2004 Sep; 19(5):365-77. PubMed ID: 15388809
[TBL] [Abstract][Full Text] [Related]
43. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
44. Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection.
Tetko IV; Sushko I; Pandey AK; Zhu H; Tropsha A; Papa E; Oberg T; Todeschini R; Fourches D; Varnek A
J Chem Inf Model; 2008 Sep; 48(9):1733-46. PubMed ID: 18729318
[TBL] [Abstract][Full Text] [Related]
45. Development of linear, ensemble, and nonlinear models for the prediction and interpretation of the biological activity of a set of PDGFR inhibitors.
Guha R; Jurs PC
J Chem Inf Comput Sci; 2004; 44(6):2179-89. PubMed ID: 15554688
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of chromatographic descriptors for the prediction of gastro-intestinal absorption of drugs.
Deconinck E; Ates H; Callebaut N; Van Gyseghem E; Vander Heyden Y
J Chromatogr A; 2007 Jan; 1138(1-2):190-202. PubMed ID: 17097093
[TBL] [Abstract][Full Text] [Related]
47. Prediction of drug absorption based on immobilized artificial membrane (IAM) chromatography separation and calculated molecular descriptors.
Yen TE; Agatonovic-Kustrin S; Evans AM; Nation RL; Ryand J
J Pharm Biomed Anal; 2005 Jul; 38(3):472-8. PubMed ID: 15890485
[TBL] [Abstract][Full Text] [Related]
48. 3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
Geldenhuys WJ; Lockman PR; Nguyen TH; Van der Schyf CJ; Crooks PA; Dwoskin LP; Allen DD
Bioorg Med Chem; 2005 Jul; 13(13):4253-61. PubMed ID: 15878282
[TBL] [Abstract][Full Text] [Related]
49. Investigating the utility of momentum-space descriptors for predicting blood-brain barrier penetration.
Al-Fahemi JH; Cooper DL; Allan NL
J Mol Graph Model; 2007 Oct; 26(3):607-12. PubMed ID: 17300970
[TBL] [Abstract][Full Text] [Related]
50. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
Usansky HH; Sinko PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
[TBL] [Abstract][Full Text] [Related]
51. Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Baert B; Deconinck E; Van Gele M; Slodicka M; Stoppie P; Bodé S; Slegers G; Vander Heyden Y; Lambert J; Beetens J; De Spiegeleer B
Bioorg Med Chem; 2007 Nov; 15(22):6943-55. PubMed ID: 17827020
[TBL] [Abstract][Full Text] [Related]
52. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
Mohr JA; Jain BJ; Obermayer K
J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
[TBL] [Abstract][Full Text] [Related]
53. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
54. Skin permeation rate as a function of chemical structure.
Katritzky AR; Dobchev DA; Fara DC; Hür E; Tämm K; Kurunczi L; Karelson M; Varnek A; Solov'ev VP
J Med Chem; 2006 Jun; 49(11):3305-14. PubMed ID: 16722649
[TBL] [Abstract][Full Text] [Related]
55. 4D-fingerprints, universal QSAR and QSPR descriptors.
Senese CL; Duca J; Pan D; Hopfinger AJ; Tseng YJ
J Chem Inf Comput Sci; 2004; 44(5):1526-39. PubMed ID: 15446810
[TBL] [Abstract][Full Text] [Related]
56. Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.
Shen M; Béguin C; Golbraikh A; Stables JP; Kohn H; Tropsha A
J Med Chem; 2004 Apr; 47(9):2356-64. PubMed ID: 15084134
[TBL] [Abstract][Full Text] [Related]
57. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
Wang XS; Tang H; Golbraikh A; Tropsha A
J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
[TBL] [Abstract][Full Text] [Related]
58. Categorical QSAR Models for skin sensitization based upon local lymph node assay classification measures part 2: 4D-fingerprint three-state and two-2-state logistic regression models.
Li Y; Pan D; Liu J; Kern PS; Gerberick GF; Hopfinger AJ; Tseng YJ
Toxicol Sci; 2007 Oct; 99(2):532-44. PubMed ID: 17675333
[TBL] [Abstract][Full Text] [Related]
59. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
[TBL] [Abstract][Full Text] [Related]
60. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
